The endocannabinoid system as a target for the treatment of motor dysfunction.

@article{FernndezRuiz2009TheES,
  title={The endocannabinoid system as a target for the treatment of motor dysfunction.},
  author={Javier Fern{\'a}ndez-Ruiz},
  journal={British journal of pharmacology},
  year={2009},
  volume={156 7},
  pages={1029-40}
}
There is evidence that cannabinoid-based medicines that are selective for different targets in the cannabinoid signalling system (e.g. receptors, inactivation mechanism, enzymes) might be beneficial in basal ganglia disorders, namely Parkinson's disease (PD) and Huntington's disease (HD). These benefits not only include the alleviation of specific motor symptoms [e.g. choreic movements with cannabinoid receptor type 1 (CB(1))/transient receptor potential vanilloid type 1 agonists in HD… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 10 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 63 extracted citations

Cannabinoids in Parkinson's Disease

View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 120 references

The endocannabinoid system in the physiology and pathophysiology of the basal ganglia

GL Gerdeman, J Fernández-Ruiz
In: Kofalvi A (ed.). Cannabinoids and the Brain. Springer-Verlag: New York, NY, pp. 423–483. • 2008
View 11 Excerpts
Highly Influenced

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

Biochemical and biophysical research communications • 1999
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…